Preventing clots after hip fracture surgery
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests whether a combination of two blood thinners (rivaroxaban and aspirin) is better than aspirin alone at preventing clots after hip fracture surgery, for people who also had a mild heart injury. It may help find a safer, more effective way to prevent dangerous blood clots.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 45 years or older and had hip fracture surgery after a low-energy fall (like tripping).
- You had a mild heart injury (elevated troponin level) around the time of surgery.
- You are not already on certain blood thinners (like rivaroxaban) or antiplatelet drugs (like clopidogrel).
- You do not have severe kidney disease (GFR under 15) or severe liver disease.
- You are not pregnant, breastfeeding, or allergic to the study drugs (rivaroxaban or aspirin).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two approaches for preventing blood clots in older adults who broke a hip. The goal is to find the safest and most effective way to manage clot risk after surgery.
This trial studies which pill regimen helps prevent dangerous blood clots after hip fracture surgery. You might be eligible if you’re 50 or older and can start treatment soon after your injury.
This study tests a shorter course of blood thinner medication (rivaroxaban) after hip replacement surgery, following an enhanced recovery plan. It aims to see if a shorter treatment can safely prevent blood clots and help you recover faster.
This trial tests a blood thinner called rivaroxaban (Xarelto) given right after heart valve surgery with a tissue valve. It aims to see if it can prevent blood clots or strokes safely in the early recovery period.
This Phase 2 study tests the best dose of low-dose aspirin to help prevent dangerous blood clots after total hip or knee replacement surgery. If you’re at lower clot risk and can safely take aspirin, it may help reduce clot risk while you recover.
This trial compares two blood-thinning strategies after leg artery surgery or angioplasty to prevent dangerous blood clots. Participants will receive either rivaroxaban plus aspirin or aspirin alone, and researchers will monitor for clots over 30 days.
Hear when a new Cardiovascular Prevention trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.